Cargando…

PPAR Agonists and Metabolic Syndrome: An Established Role?

Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated receptors (PPARs) are involved in the metabolic regulation of lipid and lipoprotein levels, i.e., triglycerides (TGs), blood gluco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botta, Margherita, Audano, Matteo, Sahebkar, Amirhossein, Sirtori, Cesare R., Mitro, Nico, Ruscica, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979533/ https://www.ncbi.nlm.nih.gov/pubmed/29662003 http://dx.doi.org/10.3390/ijms19041197

Ejemplares similares

Impact of PPAR-Alpha Polymorphisms—The Case of Metabolic Disorders and Atherosclerosis
por: Ruscica, Massimiliano, et al.
Publicado: (2019)

Influence of body variables in the development of metabolic syndrome—A long term follow-up study
por: Pavanello, Chiara, et al.
Publicado: (2018)

The Role of High-Density Lipoprotein Cholesterol in 2022
por: Sirtori, Cesare R., et al.
Publicado: (2022)

The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

“The Loss of Golden Touch”: Mitochondria-Organelle Interactions, Metabolism, and Cancer
por: Audano, Matteo, et al.
Publicado: (2020)

New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Metabolic Profile Variations along the Differentiation of Human-Induced Pluripotent Stem Cells to Dopaminergic Neurons
por: Carsana, Emma Veronica, et al.
Publicado: (2022)

Statins and C-reactive protein: in silico evidence on direct interaction
por: Shakour, Neda, et al.
Publicado: (2020)

Clinical approach to the inflammatory etiology of cardiovascular diseases
por: Ruscica, Massimiliano, et al.
Publicado: (2020)

Unravelling the health effects of fasting: a long road from obesity treatment to healthy life span increase and improved cognition
por: Wilhelmi de Toledo, Françoise, et al.
Publicado: (2020)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
por: Carugo, Stefano, et al.
Publicado: (2022)

Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function
por: Audano, Matteo, et al.
Publicado: (2014)

Rewiring of Glucose and Lipid Metabolism Induced by G Protein-Coupled Receptor 17 Silencing Enables the Transition of Oligodendrocyte Progenitors to Myelinating Cells
por: Marangon, Davide, et al.
Publicado: (2022)

Lipid Lowering Drugs: Present Status and Future Developments
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

AMPK-Dependent Metabolic Regulation by PPAR Agonists
por: Lee, Woo Hyung, et al.
Publicado: (2010)

Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
por: Greco, Maria Francesca, et al.
Publicado: (2020)

Evaluation of Transthoracic Echocardiography in the Assessment of Atherosclerosis of the Left Main Coronary Artery: Comparison with Optical Frequency Domain Imaging (a Pilot Study)
por: Labombarda, Fabien, et al.
Publicado: (2021)

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
por: Gencer, Baris, et al.
Publicado: (2021)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

Sustained IP3-linked Ca(2+) signaling promotes progression of triple negative breast cancer cells by regulating fatty acid metabolism
por: Filadi, Riccardo, et al.
Publicado: (2023)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
por: Ruscica, Massimiliano, et al.
Publicado: (2019)

Correction to: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
por: Ruscica, Massimiliano, et al.
Publicado: (2019)

Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments
por: Enayati, Ayesheh, et al.
Publicado: (2022)

Long-term fasting improves lipoprotein-associated atherogenic risk in humans
por: Grundler, Franziska, et al.
Publicado: (2021)

A PPARα agonist improves metabolic parameters in obesity
Publicado: (2012)

Ca(2+) overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
por: Raimondi, Michela, et al.
Publicado: (2021)

Author Correction: Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
por: Khuchua, Zaza, et al.
Publicado: (2018)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
por: Tsukahara, Tamotsu
Publicado: (2012)

Role of PPARα and Its Agonist in Renal Diseases
por: Cheng, Ching-Feng, et al.
Publicado: (2010)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
por: Harnchoowong, Sarawin, et al.
Publicado: (2017)

Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders
por: , Sanjay, et al.
Publicado: (2021)

Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases
por: Mansouri, Atena, et al.
Publicado: (2022)

Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats
por: Wang, Haiping, et al.
Publicado: (2010)

PPARs and Metabolic Syndrome
por: Chen, Lihong, et al.
Publicado: (2014)

Intermittent Fasting Applied in Combination with Rotenone Treatment Exacerbates Dopamine Neurons Degeneration in Mice
por: Tatulli, Giuseppe, et al.
Publicado: (2018)

SAT-LB92 Sex Hormones Therapy Differentially Modulates HDL Function in Transgender Individuals
por: Ruscica, Massimiliano, et al.
Publicado: (2020)

Effects of PPARs Agonists on Cardiac Metabolism in Littermate and Cardiomyocyte-Specific PPAR-γ –Knockout (CM-PGKO) Mice
por: Barbieri, Michelangela, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g67j011ra5k0k5891so2vvv44a